Need for clarity and context in case reports on kratom use, assessment, and intervention. Issue 1 (1st December 2022)

• Record Type: Journal Article
• Authors: Smith, Kirsten E.; Dunn, Kelly E.; Epstein, David H.; Feldman, Jeffrey D.; Garcia-Romeu, Albert; Grundmann, Oliver; Henningfield, Jack E.; McCurdy, Christopher R.; Rogers, Jeffrey M.; Schriefer, Destiny; Singh, Darshan; Weiss, Stephanie T.
• Is Part Of: Substance abuse. Volume 43:Issue 1(2022)
• Page Start: 1221
• Page End: 1224
• Publication Date: 2022-12-01
• Subjects: Kratom -- clinical assessment -- clinical diagnosis -- kratom use disorder -- kratom intervention; Substance abuse -- Periodicals; Medical education -- Periodicals; Education, Medical -- periodicals; Substance Abuse -- periodicals; 362.29
• DOI: 10.1080/08897077.2022.2074608
• Languages: English
• ISSNs: 0889-7077

Abstract

Abstract: This Letter to the Editor is a response to Broyan and colleagues who recently published a Case Report presenting data on 28 patients in the United States who identified kratom as their primary substance of use and who were subsequently induced on buprenorphine/naloxone for a reported diagnosis of kratom use disorder. We applaud the authors for helping to advance the science on kratom and recognize the difficulties in conducting kratom-related clinical assessment and research. However, a number of inconsistences and generalizations were identified in this Case Report, which also lacked some critical context. Importantly, such inconsistencies and generalizations can be observed throughout kratom-specific case reports. We feel this is now an important opportunity to highlight these issues that are present in the Broyan and colleagues Case report but emphasize that they are not unique to it. We do this with the hope that by acknowledging these issues it can help inform editors, clinicians, and researchers who may not be familiar with kratom and, as a result of this unfamiliarity, may inadvertently present findings in a manner that could confuse readers and even misinform clinical researchers and practitioners.